Home › NDC Lookup › Labelers › Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 63020 (Takeda Pharmaceuticals America, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

24
Package NDCs
30
Products
30
Active listings
0
Discontinued
6
Ingredients
0
Therapeutic classes
4
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
ponatinib hydrochloride 8
fruquintinib 6
ixazomib 6
rusfertide 5
brigatinib 4
bortezomib 1
By dosage form
CAPSULE 12
TABLET, FILM COATED 11
KIT 6
INJECTION, POWDER, LYOPHILIZED, FO... 1

Browse records — 30 products

Drug / product Billing NDC NADAC / unit Status
Alunbrig brigatinib 30 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0113-18 · 180 TABLET, FILM COATED in 1 BOTTLE (63020-113-18) 63020-0113-18 — On market View →
Alunbrig brigatinib 180 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0180-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-180-30) 63020-0180-30 — On market View →
Alunbrig brigatinib 90 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0090-07 · 7 TABLET, FILM COATED in 1 BOTTLE (63020-090-07) 63020-0090-07 — On market View →
Alunbrig brigatinib KIT Takeda · NDC 63020-0198-30 · 1 KIT in 1 CARTON (63020-198-30) * 7 TABLET, FILM COATED in 1 BOTTLE (63020-090-07) * 23 TABLET, FILM COATED in 1 BOTTLE (63020-180-23) 63020-0198-30 — On market View →
Fruzaqla fruquintinib 1 mg/1 CAPSULE Takeda · NDC 63020-0210-21 · 1 BOTTLE in 1 CARTON (63020-210-21) / 21 CAPSULE in 1 BOTTLE 63020-0210-21 — On market View →
Fruzaqla fruquintinib 5 mg/1 CAPSULE Takeda · NDC 63020-0225-21 · 1 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTLE 63020-0225-21 — On market View →
Fruzaqla fruquintinib 1 mg/1 CAPSULE Takeda · NDC 63020-0210-21 · 1 BOTTLE in 1 CARTON (63020-210-21) / 21 CAPSULE in 1 BOTTLE 63020-0210-21 — On market View →
Fruzaqla fruquintinib 5 mg/1 CAPSULE Takeda · NDC 63020-0225-21 · 1 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTLE 63020-0225-21 — On market View →
Fruzaqla fruquintinib 5 mg/1 CAPSULE Takeda · NDC 63020-0225-21 · 1 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTLE 63020-0225-21 — On market View →
Fruzaqla fruquintinib 1 mg/1 CAPSULE Takeda · NDC 63020-0210-21 · 1 BOTTLE in 1 CARTON (63020-210-21) / 21 CAPSULE in 1 BOTTLE 63020-0210-21 — On market View →
Iclusig ponatinib hydrochloride 10 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0536-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-536-30) 63020-0536-30 — On market View →
Iclusig ponatinib hydrochloride 15 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0535-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-535-30) 63020-0535-30 — On market View →
Iclusig ponatinib hydrochloride 45 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0534-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-534-30) 63020-0534-30 — On market View →
Iclusig ponatinib hydrochloride 30 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0533-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-533-30) 63020-0533-30 — On market View →
Iclusig ponatinib hydrochloride 45 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0534-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-534-30) 63020-0534-30 — On market View →
Iclusig ponatinib hydrochloride 30 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0533-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-533-30) 63020-0533-30 — On market View →
Iclusig ponatinib hydrochloride 15 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0535-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-535-30) 63020-0535-30 — On market View →
Iclusig ponatinib hydrochloride 10 mg/1 TABLET, FILM COATED Takeda · NDC 63020-0536-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63020-536-30) 63020-0536-30 — On market View →
MIMRYLO rusfertide KIT Takeda · NDC 63020-0765-60 · 1 KIT in 1 CARTON (63020-765-60) * 54 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-760-60) * .6 mL in 1 SYRINGE (63020-600-05) 63020-0765-60 — On market View →
MIMRYLO rusfertide KIT Takeda · NDC 63020-0715-10 · 1 KIT in 1 CARTON (63020-715-10) * 9.5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (63020-710-10) * .6 mL in 1 SYRINGE (63020-600-05) 63020-0715-10 — On market View →
MIMRYLO rusfertide KIT Takeda · NDC 63020-0725-20 · 1 KIT in 1 CARTON (63020-725-20) * 19 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-720-20) * .6 mL in 1 SYRINGE (63020-600-05) 63020-0725-20 — On market View →
MIMRYLO rusfertide KIT Takeda · NDC 63020-0745-40 · 1 KIT in 1 CARTON (63020-745-40) * 41 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-740-40) * .6 mL in 1 SYRINGE (63020-600-05) 63020-0745-40 — On market View →
MIMRYLO rusfertide KIT Takeda · NDC 63020-0735-30 · 1 KIT in 1 CARTON (63020-735-30) * 28 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-730-30) * .6 mL in 1 SYRINGE (63020-600-05) 63020-0735-30 — On market View →
NINLARO ixazomib 4 mg/1 CAPSULE Takeda · NDC 63020-0400-02 · 3 BLISTER PACK in 1 CARTON (63020-400-02) / 1 CAPSULE in 1 BLISTER PACK (63020-400-01) 63020-0400-02 — On market View →
NINLARO ixazomib 3 mg/1 CAPSULE Takeda · NDC 63020-0390-02 · 3 BLISTER PACK in 1 CARTON (63020-390-02) / 1 CAPSULE in 1 BLISTER PACK (63020-390-01) 63020-0390-02 — On market View →
NINLARO ixazomib 2.3 mg/1 CAPSULE Takeda · NDC 63020-0230-02 · 3 BLISTER PACK in 1 CARTON (63020-230-02) / 1 CAPSULE in 1 BLISTER PACK (63020-230-01) 63020-0230-02 — On market View →
NINLARO ixazomib 4 mg/1 CAPSULE Takeda · NDC 63020-0400-02 · 3 BLISTER PACK in 1 CARTON (63020-400-02) / 1 CAPSULE in 1 BLISTER PACK (63020-400-01) 63020-0400-02 — On market View →
NINLARO ixazomib 3 mg/1 CAPSULE Takeda · NDC 63020-0390-02 · 3 BLISTER PACK in 1 CARTON (63020-390-02) / 1 CAPSULE in 1 BLISTER PACK (63020-390-01) 63020-0390-02 — On market View →
NINLARO ixazomib 2.3 mg/1 CAPSULE Takeda · NDC 63020-0230-02 · 3 BLISTER PACK in 1 CARTON (63020-230-02) / 1 CAPSULE in 1 BLISTER PACK (63020-230-01) 63020-0230-02 — On market View →
VELCADE bortezomib 3.5 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Takeda · NDC 63020-0049-01 · J9041 · 1 VIAL in 1 CARTON (63020-049-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL 63020-0049-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.